Setup

SR Bancorp (SRBK) is a $1.14B NJ-chartered thrift that converted from mutual savings bank to stock form on September 19, 2023. Federal regulation imposes a 3-year anti-takeover window post-conversion — that window expires September 19, 2026, four months from publication. The Q1 fiscal 2026 10-Q (filed May 15, 2026) closes the only material open question on credit. The stock trades at 0.79x book ($22.63/share), sits below most institutional screens, and has one analyst covering at a $18 price target.

What the filing says

Zero non-performing assets, zero net charge-offs over nine months, zero loans modified for borrowers in financial difficulty, zero individually-evaluated impaired loans. The vintage risk-rating table shows 100% of the $862.3M loan book — multi-family $233.3M, residential mortgage $454.5M, commercial real estate $144M, C&I and consumer the balance — rated "Pass." ACL/loans 0.66%, flat versus 0.67% at June 30, 2025. The book grew $62M in nine months with zero credit deterioration.

The 2nd 10% share repurchase program (886,137 shares authorized July 8, 2025) is 86% complete: 761,229 shares retired at ≈$16.11 weighted average. Program expires July 8, 2026. At Q1 deployment pace (≈295K shares per quarter), the residual exhausts before expiry. NIM 3.00% (+18bp YoY); spread 2.55% (+30bp); CD costs -40bp YoY with $258.6M maturing within one year. Tier 1 leverage 14.26%. No strategic alternatives, no CEO transition, no CIC provisions in Item 1A.

What the market thinks

Hovde's $18 target matches the tape. Implied probability of structural event ≈ 0%. The market prices SRBK as a continuing small thrift running off acquisition accretion. Cohort community banks with sub-1% NPLs trade 1.0-1.2x P/B; SRBK at 0.79x sits 21-34% below comparable credit. The gap is identifiable, not abstract.

Why the gap exists

One analyst anchors retail to fair-value. Sub-$200M market cap sits below most institutional screens; no S&P 600 inclusion. Dividend-focused holders rotate to MMFs at 5%+ rather than collect $0.05/quarter. Mutual-holding-company conversion timing mechanics are understood inside a narrow small-cap thrift arbitrage crowd, not broadly priced. The Q1 2026 filing is what converts the catalyst from "potential" to "imminent": credit was the open question; it answered with zero classified loans across the entire book. The market has not repriced.

A second factor: SRBK's realized variance is ≈80% factor-explained (β=0.65 to market, heavy KRE loading). Statistically, the stock trades like a regional-bank ETF proxy. The catalyst is a latent factor — not in the regression because it hasn't happened. Market pricing reflects realized variance; the thesis lives outside it.

Risks (ranked)

1. Window expires without action (15-20%). Board lets the clock run, no 3rd buyback program, no advisor disclosure. Stock drifts to 0.75x P/B (-5 to -10%) pending a 2027-2028 catalyst.
2. Regional-bank sector drag (5-10%). Heavy KRE loading means an NJ regional sell-off drags SRBK independent of fundamentals. Materially mitigated by a paired KRE hedge.
3. Hidden NJ residential / multi-family credit (≈5%). Concentrated in NJ metro counties. Two clean quarters reduce but do not eliminate the risk.
4. Unfavorable second-step structure (rare). MHC mechanics can dilute existing holders if mishandled.

Catalysts

• July 8, 2026: 2nd buyback program expires. 8-K announcing a 3rd program, silence, or strategic-alternatives disclosure — all three paths are information.
• September 19, 2026: Anti-takeover window expires. M&A or second-step conversion legally available from this date.
• ~October 2026: FY2026 10-K filing — confirms or breaks the credit thesis at fiscal year-end.
• September 19, 2027: Outer bound for first-12-month post-window M&A.

Forward probabilities: 0.75 on a 3rd buyback authorized by Sep 30; 0.78 on zero NPLs at FY26 year-end; 0.40 on a structural event (M&A, second-step, strategic alternatives, or recap >$5M) by Dec 31, 2026; 0.30 on outright M&A within 12 months post-window.

What would change our mind

A non-performing loan emerging in the Q4 FY26 10-K. The 2nd buyback program lapsing without renewal AND no strategic disclosure by July 31, 2026. CEO turnover or compensation reset suggesting incumbents are entrenching. NJ regional bank sector showing systemic credit deterioration with peers reporting elevated NPLs. Idio variance verification (open gap) revealing the position is structurally a sector trade rather than an idio bet — would force the SRBK / KRE pair structure to become primary rather than optional.

Evidence